[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "summary": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=4eed4874cfa240b97ed5df4ad8cd37af74027bd476cd92ff24ad581559af3877",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748623020,
      "headline": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
      "id": 134943368,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=4eed4874cfa240b97ed5df4ad8cd37af74027bd476cd92ff24ad581559af3877"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated (VRTX) Bernstein 41st Annual Strategic Decisions Conference (Transcript)",
    "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Bernstein 41st Annual Strategic Decisions Conference May 30, 2025 8:00 AM ETCompany ParticipantsReshma...",
    "url": "https://finnhub.io/api/news?id=f8e6ba9477818753dca4a5cad568096c8a5a0b12d1430801657a460dc4179380",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748602896,
      "headline": "Vertex Pharmaceuticals Incorporated (VRTX) Bernstein 41st Annual Strategic Decisions Conference (Transcript)",
      "id": 134903621,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Bernstein 41st Annual Strategic Decisions Conference May 30, 2025 8:00 AM ETCompany ParticipantsReshma...",
      "url": "https://finnhub.io/api/news?id=f8e6ba9477818753dca4a5cad568096c8a5a0b12d1430801657a460dc4179380"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Vertex Pharmaceuticals Incorporated Presents at Bernstein 41st Annual Strategic Decisions Conference 2025, May-30-2025 08",
    "summary": "Presenter SpeechWilliam Pickering All right. Well, I think we can get started. Good morning, everyone. My name is Will Pickering. I cover U.S. biotech at Bernstein. I am privileged to be joined",
    "url": "https://finnhub.io/api/news?id=1e3976c6f7218c677486def4fa2dcfcd6e94991ff46f4cddb8d916ca5000ebff",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748596833,
      "headline": "Transcript : Vertex Pharmaceuticals Incorporated Presents at Bernstein 41st Annual Strategic Decisions Conference 2025, May-30-2025 08",
      "id": 134896182,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "Presenter SpeechWilliam Pickering All right. Well, I think we can get started. Good morning, everyone. My name is Will Pickering. I cover U.S. biotech at Bernstein. I am privileged to be joined",
      "url": "https://finnhub.io/api/news?id=1e3976c6f7218c677486def4fa2dcfcd6e94991ff46f4cddb8d916ca5000ebff"
    }
  },
  {
    "ts": null,
    "headline": "abrdn Healthcare Investors Q1 2025 Commentary",
    "summary": "abrdn Healthcare Investors Q1 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=08a995b94c9843618fb019a74515636093294d133726b11dc86cee43c76ca7fd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748595900,
      "headline": "abrdn Healthcare Investors Q1 2025 Commentary",
      "id": 134895434,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=08a995b94c9843618fb019a74515636093294d133726b11dc86cee43c76ca7fd"
    }
  },
  {
    "ts": null,
    "headline": "abrdn Focused U.S. Small Cap Active ETF Q1 2025 Commentary",
    "summary": "The Fund fell (gross of fees) but outperformed the Russell 2000 Index. Read more here.",
    "url": "https://finnhub.io/api/news?id=95e47289f66aad913156d6e5be3595ca3be826c4d600e560f937374f79face95",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748590500,
      "headline": "abrdn Focused U.S. Small Cap Active ETF Q1 2025 Commentary",
      "id": 134893895,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1256967959/image_1256967959.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "The Fund fell (gross of fees) but outperformed the Russell 2000 Index. Read more here.",
      "url": "https://finnhub.io/api/news?id=95e47289f66aad913156d6e5be3595ca3be826c4d600e560f937374f79face95"
    }
  },
  {
    "ts": null,
    "headline": "Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks",
    "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Biogen (NASDAQ:BIIB).",
    "url": "https://finnhub.io/api/news?id=5e602a9d616ac83a6a50a36419ece3ad23b7b2a464982b92055c69e8d8bb99b2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748576096,
      "headline": "Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks",
      "id": 134899349,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Biogen (NASDAQ:BIIB).",
      "url": "https://finnhub.io/api/news?id=5e602a9d616ac83a6a50a36419ece3ad23b7b2a464982b92055c69e8d8bb99b2"
    }
  }
]